CARDIac Arrest and Cardiogenic Shock

Each year in the United States, approximately 400,000 sudden cardiac arrests occur outside the hospital, with a survival rate of only 12%. To help meet the need for next-generation cardiovascular diagnostic tools and therapeutics MCIRCC has developed a comprehensive approach to understanding the pathophysiology of cardiac arrest, cardiogenic shock, and other critical cardiovascular conditions. The fundamental challenges addressed by our program are to discover and translate new precision diagnostic and treatment strategies that are uniquely designed to provide the right treatment at the right time. This will enable the field to move away from the one-size-fits all approaches of the past to more innovative therapies of the future.

 

Licensed and Emerging Products

 

Research Grants

Cardiac Arrest and Cardiogenic Shock Headlines: